HD-101 (Hanwha)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHD-101 (Hanwha)
Drug Alias Nameantibody (Dreampharma)HD-101
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsAutoimmune DiseasesMultiple SclerosisAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDreamPharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesMultiple SclerosisAsthma

Other Information

ATC CodeN/A
Related LinksN/A